Cyramza
Drug timelines are a Plus or Pro feature.
45 regulatory and trial events tracked for Cyramza, covering 2014-04-21 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]